论文部分内容阅读
目的：进一步探讨低能量氦氖激光血管内照射（ＩＬＩＢ）对脑动脉硬化患者的治疗机制，观察治疗前后血浆Ｄ－二聚体（Ｄ－Ｄ）、过氧化脂质（ＬＰＯ）、超氧化物歧化酶（ＳＯＤ）及主要临床症状变化。方法：对４０例脑动脉硬化患者选择肘正中静脉采用ＩＬＩＢ疗法，功率２．５ｍＷ／ｃｍ２照射６０分钟，每日１次，１０次为１疗程。于治疗前和疗程后采空腹静脉血测定上述指标并进行ｔ检验。结果：治疗后血浆Ｄ－Ｄ和ＬＰＯ值下降，ＳＯＤ值上升，主要临床症状改善。结论：ＩＬＩＢ可降低血液高凝状态，提高机体抗氧化机能，减轻自由基对机体的损伤。
Objective: To further explore the therapeutic mechanism of low-energy He-Ne laser intravascular irradiation (ILIB) on cerebral arteriosclerosis in patients with cerebral arteriosclerosis. The levels of plasma D-D, LPO and superoxide Dismutase (SOD) and the main clinical symptoms. Methods: In 40 patients with cerebral arteriosclerosis, the elbow median vein was treated with ILIB therapy. The power of 2.5mW / cm2 was given for 60 minutes, once daily and 10 times as a course of treatment. Before treatment and after treatment, fasting venous blood was taken to measure the above parameters and t test. Results: After treatment, plasma D-D and LPO decreased, SOD increased, the main clinical symptoms improved. Conclusion: ILIB can reduce blood hypercoagulability, enhance the body’s antioxidant capacity and reduce the damage of free radicals on the body.